Quick Takeaways
- Redmile Group, LLC filed SCHEDULE 13D/A for IGM Biosciences, Inc. Common Stock, par value $0.01 per share (IGMS).
- Disclosed ownership: 0%.
- Date of event: 14 Aug 2025.
Redmile Group, LLC - 14 Aug 2025 SCHEDULE 13D/A Report for IGM Biosciences, Inc. Common Stock, par value $0.01 per share (IGMS)
- Filing Manager
- Redmile Group, LLC
- Reporting Manager
- Redmile Group, LLC
- Symbol
- IGMS
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13D/A
- Filing time
- 15 Aug 2025, 17:01:03 UTC
- Date of event
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Redmile Group, LLC disclosed 0% ownership in IGM Biosciences, Inc. Common Stock, par value $0.01 per share (IGMS) on 14 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 Aug 2025, 17:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Redmile Group, LLC | 0% | 0 | 0 | 0 | /s/ Jeremy C. Green | Managing Member | 0001425738 |
| Jeremy C. Green | 0% | 0 | 0 | 0 | /s/ Jeremy C. Green | Jeremy C. Green | 0001650527 |